FDA | What's New
Follow
Replacing and Reducing Animal Testing at CDER
It has become increasingly clear that new approach methodologies (NAMs)—when combined with knowledge of the pathway, results of pharmacology studies, and other relevant data—may offer ways to reduce animal testing.
